NEW YORK, Dec. 5 /PRNewswire-FirstCall/ -- The Board of Directors of Bristol-Myers Squibb Company today declared a quarterly dividend of twenty-eight cents ($0.28) per share on the $.10 par value Common Stock of the corporation. The quarterly dividend will be payable on February 1, 2007 to stockholders of record at the close of business on January 5, 2007.
The Directors also declared a quarterly dividend of fifty cents ($0.50) per share on the $2.00 Convertible Preferred Stock of the corporation, payable March 1, 2007 to stockholders of record at the close of business on February 2, 2007.
As previously announced, the Board of Directors has indicated an expected dividend for the full year of 2007 of $1.12 per share, subject to the normal quarterly review by the Board. The indication is also subject to the outcome of the pending PLAVIX(R) patent litigation scheduled to commence on January 22, 2007 and the absence of sustained generic competition for PLAVIX(R) in 2007.
Bristol-Myers Squibb Company is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.
Bristol-Myers Squibb CompanyCONTACT: Media, Jeff Macdonald, Communications, +1-212-546-4824,jeffrey.macdonald@bms.com; or Investors, John Elicker, Investor Relations,+1-212-546-3775, john.elicker@bms.com
Web site: http://www.bms.com/
